The determination of the relapse risk of chronic myeloid leukemia using the indicators of the functional activity of bone marrow and sokal index von D. I. Bilko, I. O. Zhaleiko, T. P. Perekhrestenko, I. S. Diahil

Volltext

Determination of the optimal chemotherapy drugs pretreatment time through cultivation of hemopoietic cells in CML-patients treated with tyrosine kinase inhibitors von I. O. Zhaleiko, T. P. Perekhrestenko, D. I. Bilko, I. S. Dyagil, N. M. Bilko

Volltext

Functional activity of CD34-positive cells in chronic myeloid leukemia patients with different response to imatinib therapy von I. O. Sviezhentseva, T. P. Perekhrestenko, D. I. Bilko, A. I. Gordienko, M. V. Diachenko, I. S. Dyagil

Volltext